ArticleActive
Billing and Coding: Thyroid Nodule Molecular Testing
A58656
National Government Services, Inc. (J06)
Effective: July 1, 2024
Updated: December 31, 2025
Policy Summary
This billing and coding guidance complements the LCD for thyroid nodule molecular testing and requires that testing meet the LCD's clinical and medical necessity criteria. Claims must include a valid ICD-10-CM diagnosis code, and when applicable must report the referring/ordering physician name and NPI; procedure codes may be subject to NCCI or OPPS packaging edits. The medical record must document medical necessity, including history, physical exam, and pertinent diagnostic test results, and diagnostic test results should be reported on the claim if known.
Coverage Criteria Preview
Key requirements from the full policy
"Thyroid nodule molecular testing is covered when it meets the clinical indications and medical necessity criteria specified in the attached Local Coverage Determination (LCD)."
Sign up to see full coverage criteria, indications, and limitations.